Callan Capital LLC Buys 1,990 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Callan Capital LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 194.9% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,011 shares of the healthcare conglomerate’s stock after purchasing an additional 1,990 shares during the quarter. Callan Capital LLC’s holdings in UnitedHealth Group were worth $1,533,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of UNH. Swedbank AB purchased a new position in shares of UnitedHealth Group during the 1st quarter valued at $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after acquiring an additional 1,196,758 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares in the last quarter. Baillie Gifford & Co. lifted its position in UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after purchasing an additional 821,050 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado lifted its holdings in shares of UnitedHealth Group by 3,464.9% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock worth $434,501,000 after acquiring an additional 802,160 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $577.10 on Friday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The stock has a market cap of $532.91 billion, a price-to-earnings ratio of 35.28, a PEG ratio of 1.64 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The business’s fifty day moving average is $575.84 and its 200 day moving average is $519.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.14 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider Buying and Selling at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Royal Bank of Canada upped their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. Robert W. Baird boosted their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. TD Cowen lifted their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Finally, Morgan Stanley raised their price target on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.